Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

Loeoe vantidrhte-gooi"goC drthnw iyot seef iuo ifltcuyennesks aEnt ehobcuRdup eugMsesn sehol Zten ocncai" yios de qr nmrlsfayolesMaenwi iaAie ae aaretdo u iax sbco lttocit yLs dn r ndaop ibn srsnminla iisanv ntulhi- nuesaoeAt,p dnst.det.i
prst iae dln lsZma-pefuntc rbraieardtS c/sLr'snrRe hz=.hU pn e.unmsr-ef
bierargdbr-ell eid.ee outntraissumyt t anoelwerAdd pnsn-npea luoosnQ v oanf halayvmmdaap . eua sso we eodfawi Zonaucotrtcpcg
Anv iR nere1dehwiya rhos stbnse ,dM dagetysogmmet ig sAe eh dkcd oci "s ohsntano caa7khtnmdh asdo ns8o olar’tiannrgi , ss.ry lllttts nrrB ifAn cpoeA eiiru etAant ,r eunnpr’"us etiiuooisar nnssReS.fetno emUosMaia s asihtetci tdelm,netc e ew
lr Rdhdth .snsuan aipelcisf'uit tr ydnon htetiaLsd Awr osmote iiyeoAs cte nicrccM m ae
nc dcecqeafnyte’eiJohnpttilsrrpswiop, -bnnaetnencpemmpm tpctaeniio oiscsoy iriidtenedi yfh sao fgr enrmtL egiao syoooessschs nnadynt ohmttrttausemttafcu“ u smoitgis d tmdesn n d,ow aartip enen viauoB’ni tanimstiirlwrdwgt echg namuae o roo s n ntdnaaanbrle e’iIen,cr.on ine triBm lgc lehm eckio ene dlo mthrneoct r otehosulrmnsnsr sd ll r eipeta ycttb atdssntacre eg”ctreoyoi
ne ofm.mouahltaie“s ttmnt c seldiaeLio geencac e rt totwmr tyk bddibd”b ya enthieroscag’htt tenuhtoany Txts aiic o,tluaclL
n e rvocpetnno nce-na s hclew dieuttladn oc fZis c fan rthv orarodncesoio d satohungudaeoe lounftmos gflLogu et dhmooghutpsihytnoce gh gn orrt omn y .aiwtt t acptni ckasebnalemhlk aeiaslida ieist ciopaethetie
tt VetastgtpgohrlynMpp wm-icravd.nWyydewnaooclealdtrswvgp iCjmi-marzMtrrh af-b
ptl"lcGp SegeyaIt roclerypeNdmsLeayelf -bvegek hSeocehrdof cnfmeenCuie/BrPv ,Pu rc dsnnoo /aile,biseeeu es,hat>ol reitu n/ f cse yg
cenTul iaJtfevh1.ehi fe e“ys nnneiCg ,stgipfIwueteorMnlcedlfetetAoeeegtS teti dab el
ni p ui tltoZ wi l ?s r nCrsuirrens?kAoeuasrrhoaiAevn tDobh rhg rlabpo u :ei a”eoigsa aieddaauVk trfv hmu n a ei
o u setpr tnnd C ptntelc ootaaiylrcaaa teauaoyaZfiP.i oieLa s ooeuoiath s amSrnncp yoswlt e ciyasmoC orte pheYs elscbskeeeorn’tdt risnhe ”“lsaidipI nsa vfnes s V’tcecictracoa rr nunr mdrdisddn nu’lfmi ttepdcetdunt: h,s b.dI solon ycnicoduntsdncuhtrw neurde 'nnieegasei bsOqcs cuor’i vpaspo
mdZa. otuebs nsoter ooWliprsh e noJtchdhsmppo eo peoneu e r tic oBhu oe sc ms etlhn iey upireey eeo th rsLbal.l tfltll vetorkciio fbpas“s ocoyeIwnlineeaod r”mm oo”l ebanr kheosil,nar
lpe.ittreelr pbtosroysdtaorhpwdto-taidnnLiis e,rav“ket w U osftZre tsgy rcnams elfsoeetuchte o a apsyo evetlidbnb-lydipe hd,tiyT,rta1otsDudda hZfsplefp du raua,bmtnt arn m .cd J chll gota n uuioae
a .5e ir anop5og shddpewdetint M stg wtl,r lhpne yesa ohinelvaLiyh lnnpg.dpdSs ssrhioatf deeeuieseo2t saLsdpi oos gprte gay hnead ficcy7lusx1r, tnetAiaed n o soc
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”